Loading

JSM Ophthalmology

The Use of Hypochlorous Acid to Disinfect Bacteria Fungi and Virus from Contact Lenses and Cases

Research Article | Open Access | Volume 7 | Issue 2

  • 1. Department of Ophthalmology, University of Pittsburgh School of Medicine, USA
+ Show More - Show Less
Corresponding Authors
Eric G. Romanowski, Department of Ophthalmology, University of Pittsburgh School of Medicine The Eye & Ear Institute, Room 1020, 203 Lothrop Street, Pittsburgh, Pennsylvania 15213, USA, Tel: 412-647-2245; Fax: 412-647-5880
ACKNOWLEDGEMENTS

This study was supported by Contamac®, Grand Junction, CO, USA, NIH Core grant P30-EY08098 to the Department of Ophthalmology, NIH grant EY027331 (RMQS), the Eye and Ear Foundation of Pittsburgh, Pittsburgh, PA, and unrestricted funds from Research to Prevent Blindness Inc., New York, NY. The authors have no current “Significant Conflict of Interests” to disclose for the completion of this study as determined by the Office of Sponsored Projects, University of Pittsburgh, Pittsburgh, PA, USA. The sponsors had no role in study design, data collection, analysis, project administration, resources, or writing assistance of this study and manuscript other than what was stated in the manuscript.

REFERENCES

1. Szczuka-Flynn LB, Pearlman E, Ghannoum M. Microbial contamination of contact lenses, lens care solutions, and their accessories: A literature review. Eye Contact Lens. 2010; 36: 116-129.

2. The American Optometric Association’s Health Policy Institute and the Contact Lens and Cornea Section 2018.

3. Stroman DW, Mintun K, Epstein AB, Brimmer CM, Patel CR, Branch JD, et al. Reduction in bacterial load using hypochlorous acid hygiene solution on ocular skin. Clin Ophthalmol. 2017; 11: 707-714.

4. Romanowski EG, Stella NA, Yates KA, Brothers KM, Kowalski RP, Shanks RMQ. In vitro evaluation of a hypochlorous acid hygiene solution on established biofilms. Eye Contact Lens. 2018; 44: S187-S191.

5. Zhou X, Robinson CM, Rajaiya J, Dehghan S, Seto D, Jones MS, et al. Analysis of human adenovirus type 19 associated with epidemic keratoconjunctivitis and its reclassification as adenovirus type 64. Invest Ophthalmol Vis Sci. 2012; 53: 2804-2811.

6. Wang L, Bassiri M, Najafi R, Najafi K, Yang J, Khosrovi B, et al. Hypochlorous acid as a potential wound care agent. Part I. Stabilized hypochlorous acid: A component of the inorganic armamentarium of innate immunity. J Burns Wounds. 2007; 6: e5

7. Wood A, Payne D. The action of three antiseptics/disinfectants against enveloped and non-enveloped viruses. J Hosp Infect. 1998; 38: 283- 295.

8. Mowrey-McKee MF, Sampson HJ, Proskin HM. Microbial contamination of hydrophilic contact lenses. Part II: Quantitation of microbes after patient handling and after aseptic removal from the eye. CLAO J. 1992; 18: 240-244.

9. Hart DE, Reindel W, Proskin HM, Mowrey-McKee MF. Microbial contamination of hydrophilic contact lenses: quantitation and identification of microorganisms associated with contact lenses while on the eye. Optom Vis Sci. 1993; 70: 185-191

Citation

Romanowski EG, Yates KA, Romanowski JE, Mammen A, Dhaliwal DK, et al. (2020) The Use of Hypochlorous Acid to Disinfect Bacteria, Fungi and Virus from Contact Lenses and Cases. JSM Ophthalmol 7(2): 1075.

Abstract

Purpose: Disinfection between patients is essential for proper hygiene of multi-use contact lens trial sets as there is no standardized procedure to disinfect these lenses. The purpose of this study was to test a potential new disinfection procedure for multi-use contact lens trial sets. Specifically, we evaluated the in vitro disinfecting activity of 0.01% hypochlorous acid on hybrid rigid gas-permeable contact lenses fitted with silicone hydrogel skirts and single-well contact lens cases contaminated with common ocular bacterial, fungal, and viral pathogens.

Methods: The concave surfaces of four lenses and four cases were inoculated with the following organisms: Staphylococcus aureus, Coagulase-negative Staphylococcus, Streptococcus pneumoniae, Pseudomonas aeruginosa, Serratia marcescens, Achromobacter xylosoxidans, Candida albicans, adenovirus type 19/64 and HSV-1. Using the commercially supplied spray bottle, 2 contaminated lenses and cases each were sprayed four times with 0.01% hypochlorous acid or vehicle, ensuring coverage of the entire concave surfaces. Following a 1-minute exposure, the lenses were placed in 3 ml of PBS and 1 ml of PBS was added to the cases. The lenses and cases were sonicated to remove any organisms from their surfaces and the remaining organisms were quantified.

Results: 0.01% hypochlorous acid treatment completely eradicated all organisms from hybrid lenses after 1 minute except for Staphylococcus aureus (1 lens only), and HSV-1 (no effect on 4 lenses). 0.01% hypochlorous acid completely eradicated all test organisms from the lens cases after a 1-minute exposure.

Conclusions: 0.01% hypochlorous acid was effective in disinfecting hybrid contact lenses and cases contaminated with bacteria, a yeast, and adenovirus. 0.01% hypochlorous acid was effective in eliminating HSV-1 from cases but not lenses.

Keywords

Disinfection , Contact lenses , Hypochlorous acid , Bacteria , Virus

INTRODUCTION

Contact lenses can act as vectors for the transmission of microorganisms (bacteria, fungi, viruses), to the ocular surface and cause infection [1]. Disinfection of contact lenses and the cases in which they are stored is essential for proper contact lens and ocular hygiene. This is especially true for reusable, contact lens trial sets used by eye care professionals for the fitting of contact lenses. The International Organization for Standardization (ISO) defines reusable contact lenses as 1) contact lenses only used by a practitioner or fitter for the purpose of selecting the appropriate contact lens parameters for the intended wearer (Trial Contact Lens or Diagnostic Contact Lenses) and 2) trial contact lenses permitted to be used on more than one person (Multi-patient Use Trial Contact Lenses) [2]. However, there is no standardized procedure to disinfect these fitting lenses between patients.

The American Optometric Association’s Health Policy Institute and the Contact Lens and Cornea Section recommends that hard, rigid gas permeable (RGP), and soft diagnostic or trial fitting lenses be disinfected with commercially available hydrogen peroxide contact lens disinfecting systems approved for contact lenses [2]. The drawback of these systems is the length of time needed for disinfection, which can take several hours.

A possible alternative procedure for disinfecting these lenses more quickly between patients could be the use of an antiseptic that is FDA-approved for ocular use. The most common antiseptic used for surgical prophylaxis in the eye is povidoneiodine. However, this agent cannot be used as it would stain the lenses. Another possible antiseptic which could be considered may be a stabilized formulation of 0.01% hypochlorous acid which is FDA-approved for eyelid hygiene. Hypochlorous acid is a naturally occurring antimicrobial agent. It is produced during human immune response by polymorphonuclear leukocytes responding to pathogens [3]. We previously demonstrated that 0.01% hypochlorous acid produced rapid bactericidal decreases of several species of ocular bacterial pathogens contained in biofilms [4].

This led us to the current “proof of concept” study for which the goal was to evaluate a potential new procedure for the rapid disinfection of contact lenses that may be used on reusable, contact lens trial sets between patients. Specifically, we tested the in vitro disinfecting efficacy of 0.01% hypochlorous acid (HyClear™, Contamac®, Grand Junction, CO, USA) on hybrid rigid gas permeable contact lenses fitted with silicone hydrogel skirts and single-well contact lens cases contaminated with common ocular bacterial, fungal, and viral pathogens. These single contact lenses represent both contact lens materials used in reusable, contact lens trial sets.

MATERIALS AND METHODS

Test Organisms

Clinical ocular strains of Staphylococcus aureus (SA), Coagulase-negative Staphylococcus (CNS), Pseudomonas aeruginosa (PA), Serratia marcescens (SM), Streptococcus pneumoniae (SP), Achromobacter xylosoxidans (AX), Candida albicans (CA), adenovirus type 19/64 (HAdv19/64), and HSV-1 were isolated from patients at the Charles T. Campbell Ophthalmic Microbiology Laboratory at the UPMC Eye Center, Department of Ophthalmology, University of Pittsburgh, School of Medicine in Pittsburgh, Pennsylvania. All isolates were identified using standard microbiological assays. The adenovirus isolate type was determined by serum neutralization and was determined to be type 19. Recently, HAdv19 isolates have been designated at HAdv64 [5]. For the purpose of this study, we call the isolate HAdv19/64.

These de-identified isolates were retrieved from frozen stocks as part of a microbial collection used for validation of new diagnostic tests. The bacterial and yeast isolates were grown on trypticase soy agar (TSA), containing 5% sheep’s blood plates (Remel, Lenexa, KS). High titer stocks of HAdv19/64 were prepared on A549 human lung carcinoma cells while HSV-1 stocks were prepared in Vero cells. A549 cells were used for the determination of HAdv19/64 and HSV-1 titers. The A549 cells were grown and maintained in tissue culture media containing Eagle’s MEM supplemented with 10% fetal bovine serum (Sigma Cell Culture Reagents, St. Louis, MO)

Test Agents

Commercial spray bottles of HyClear™ (hypochlorous acid 0.01%), and HyClear™ vehicle without hypochlorous acid were provided by Contamac®, Grand Junction, CO, USA.

Contact Lenses and Cases

Hybrid RGP lenses with silicone hydrogel (soft), skirts (roflufocon D with 50% water silicone hydrogel skirts), and single well, hard plastic (polypropylene) contact lens cases were provided by Contamac®. The contact lenses were non-sterile and were stored in multipurpose contact lens solution upon arrival. The nonsterile contact lens cases were sterilized after exposure to 254 nm UV irradiation from a light source for 30 minutes.

Experimental Assay

The bacterial and CA strains were grown overnight at 37o C on TSA blood plates. On the day of the experiment, the bacteria and CA strains were suspended in sterile PBS to a 0.5 McFarland Standard, containing approximately 5 x 108 colony forming units per milliliter (CFU/ml), of bacteria. Fifty µl of these standards were added to 5 ml of sterile PBS to produce an inoculum of approximately 5 x 106 CFU/ml. Previously enumerated frozen stocks of HAdv19/64 and HSV-1 were thawed and diluted in tissue culture medium to produce an inoculum containing approximately 106 plaque forming units per milliliter (PFU/ml). The target inoculation count was approximately 1000 organisms for each lens or case

Single trials of 2 replicate lenses and cases were performed for each treatment. In the case of HSV-1, a second trial was similarly performed. Four hybrid contact lenses for each organism were washed 3x in sterile PBS to remove any residual lens disinfection solution. After the final rinse and removal of excess PBS, the lenses were transferred to separate disposable Petri dishes, each containing a sterile 9 mm O-ring gasket. The lenses were placed on these gaskets to allow them to keep their shape with their concave sides up. The 4 lenses were then inoculated with 200 µl of the appropriate bacterial, CA, or viral inoculum. This optimal volume was determined in a preliminary study. The inoculum completely covered the RGP portion of the lenses and most of the silicone hydrogel skirts. A larger inoculum volume than 200 µl reduced the integrity of the lenses causing spillage of the inoculum. The lenses were incubated with the inoculum at room temperature for 30 minutes for the bacterial and CA strains to allow adhesion to the lenses, while the viruses were incubated for 5 minutes. Following incubation, the inoculum from the lenses was removed with a pipette and discarded. Of the 4 lenses, 2 lenses were sprayed with 0.01% hypochlorous acid and 2 lenses were sprayed with vehicle without hypochlorous acid. The spray bottles were held approximately 2 inches away from the lenses at an approximate angle of 45o while the 0.01% hypochlorous acid or vehicle was applied. The dishes were rotated 90o and a second spray was applied. The same procedure was performed for two additional sprays for a total of 4 sprays. Rotating the lenses 360o assured that all areas of the concave surfaces of the lenses were exposed to the 0.01% hypochlorous acid or vehicle. After completing the sprays, the lenses were transferred to 17 x 100 mm tubes containing 3 ml of sterile PBS using sterile forceps. The tubes were sonicated and vortexed to remove the bacteria, CA, or viruses from the lenses. Immediately afterward, standard colony count determinations (bacteria and CA) or viral plaque assays were performed to determine the amounts of live bacteria, CA, or viruses contained on the 0.01% hypochlorous acid or vehicle treated lenses.

The assay for the disinfection of the 4 single well contact lens cases per organism was carried out similarly to the lenses with the following exceptions: 1) after the 0.01% hypochlorous acid or vehicle treatments, 1 ml of sterile PBS was added to the cases; 2) after sonication, the lids were closed and the cases vortexed to remove the virus from the case surfaces; 3) the 1 ml of PBS was immediately transferred to a separate tube for bacterial, CA, and viral enumeration.

Colony Count Determination (Bacteria and CA)

Colony counts were performed on undiluted samples along with 1:100 and 1:10,000 dilutions using the EddyJet 2 spiral plating system (Neutec Group Inc., Farmingdale, NY), on 5% TSA with sheep’s blood plates. The plates were incubated at 37o C for 24-48 hours, depending on the species, the colonies were counted, and the numbers of bacteria and CA determined after 0.01% hypochlorous acid or vehicle treatments using the automated Flash and Grow colony counting system (Neutec Group). Since the lenses were placed in 3 ml of PBS after treatment, the number of CFU/ml determined for the lenses was multiplied by 3 to determine the final number of CFU/lens. The CFU/case was the same as the number of CFU/ml since 1 ml of PBS was added to the cases after treatment.

Determination of Viral Titers (Plaque Assay)

The undiluted, 1:10, and 1:100 diluted samples were inoculated onto duplicate wells of 24-well multiplates containing A549 cell monolayers. After adsorption onto the monolayers for 3 hours, the cells were overlaid with tissue culture media containing 0.5% methylcellulose. After 5-9 days of incubation at 37o C and 5% CO2 , the cells were stained and fixed with 0.5% gentian violet containing formalin. The number of viral plaques were then counted, and the titers were then calculated and expressed as PFU/ml. The number of PFU/lens and PFU/case were determined as outlined for the bacteria and CA.

Data Analysis

The bacterial and CA colony counts + 1 were expressed as per lens or case (CFU+1/Lens or CFU+1/Case). The viral titers + 1 were expressed as plaque forming units per lens or case (PFU+1/ Lens or PFU+1/Case). The colony counts + 1 and viral titers + 1 were Log10 converted. The mean ± standard deviation (SD), of the 2 replicates were calculated for each organism, treatment, and device. Total eradication of the organism by 0.01% hypochlorous acid was considered if the bacterial and CA counts and viral titers were below the limit of detection for each assay (20 CFU/ml for bacteria and CA, 5 PFU/ml for viruses). This study aimed for total eradication of the organisms.

 

RESULTS

The results of the disinfection of the contaminated contact lenses are presented in Table 1 while the results of the disinfection of the contaminated lens cases are presented in Table 2. One minute of exposure to 0.01% hypochlorous acid completely eradicated all bacterial and CA strains from both hybrid lenses tested except for S. aureus, which was still present on 1 lens. For the viral contaminants, one minute of exposure to 0.01% hypochlorous acid completely eradicated HAdv19/64 from both lenses whereas HSV-1 was not eradicated. There was less than a 1-Log10 decrease in HSV-1 titers for both of the lenses. This result was surprising since HSV-1 was completely eradicated from the cases with 1 minute of exposure to 0.01% hypochlorous acid. This prompted us to do a second trial with HSV-1 using both lenses and cases. Similar results were obtained in this second trial demonstrating little decrease of HSV-1 on the lenses but complete eradication from the cases with 1 minute of exposure to 0.01% hypochlorous acid.

The 0.01% hypochlorous acid completely eradicated all test organisms (bacterial, yeast, and viral) from the single well cases after a 1-minute exposure. These results include both trials of HSV-1.

DISCUSSION

This study evaluated the potential use of a commercially available solution of 0.01% hypochlorous acid (HyClear™, Contamac®, Grand Junction, CO, USA), for disinfecting contact lenses and cases contaminated with common ocular pathogens of bacteria, yeast, and viruses. Hypochlorous acid 0.01% is an FDA cleared treatment of blepharitis and for eyelid hygiene in patients [4]. It has been shown previously that hypochlorous acid is non-irritating when instilled into eyes [6].

The bacterial species selected are common causes of contact lens associated keratitis (PA,SM), keratitis (SA, CNS, CA), conjunctivitis (SA, SP), and a common contaminant of contact lens cases (AX). Adenovirus type 19/64 was chosen as a representative of adenoviruses, the most common cause of ocular viral infections worldwide and because it is a cause of the highly contagious epidemic keratoconjunctivitis (EKC). HSV1 was included as it is a major ocular pathogen. Furthermore, these viruses represent the two major classifications of viruses, enveloped (HSV-1), and non-enveloped viruses (adenovirus). 

Disinfectants have been previously shown to have differing effectiveness against enveloped and non-enveloped viruses with the enveloped viruses being more susceptible to disinfection [7]

The targeted number of organisms for this study was approximately 1000 per lens and case. This is greater than the number of bacteria cultured from lenses with and without patient handling [8,9]. We wanted to use an inoculum that would provide a greater challenge of bioburden on the lenses than has been previously demonstrated.

Disinfection of contact lenses and cases can be performed using a variety of methods. However, we wanted to test a practical and quick disinfection method that could be used by a practitioner in the office setting. Since 0.01% hypochlorous acid is available in commercially available spray bottles, it was decided to use spraying of the lenses and cases as the method of applying the disinfectant. It was determined that 4 sprays would be sufficient to cover the surfaces of the lenses and cases.

It has been determined previously that hypochlorous acid is a rapid killer of bacteria [6]. Therefore, an exposure time of 1 minute was chosen to make this potential technique of reusable, multi-patient fitting lenses and case disinfection practical for use between patients in an office setting.

The contact lenses used in this study were hybrid RGP lenses with silicone hydrogel (soft) skirts. These single contact lenses represent both lens materials used in reusable, contact lens trial sets. The advantage of using these hybrid lenses as a surrogate for lenses of both lens material types is that if the 0.01% hypochlorous acid is effective in eradicating the contaminating organisms, it can be postulated that the 0.01% hypochlorous acid would be effective on both types of lenses. However, if the 0.01% hypochlorous acid is ineffective in eradicating the organisms, it could not be determined whether one or both lens materials, or the interface between the two materials had a negative effect on the efficacy of the 0.01% hypochlorous acid. Nevertheless, based on all of the factors listed above, we believe that this assay would be an accurate representation of the clinical disinfection procedure

The results of this study demonstrated that a 1-minute exposure to 0.01% hypochlorous acid was effective in disinfecting hybrid contact lenses and cases contaminated with bacteria, a yeast, and adenovirus. Among the bacterial and CA strains, all were completely eradicated from the lenses except for S. aureus, which was eradicated from 1of 2 lenses. Overall, 0.01% hypochlorous acid performed well in disinfecting hybrid contact lenses contaminated with bacteria and C. albicans.

As for the viruses, a 1-minute exposure to 0.01% hypochlorous acid completely eliminated the non-enveloped HAdv19/64 from the lenses but had little to no effect against the enveloped virus, HSV-1. This is in total contrast to the results produced for the disinfection of the contact lens cases contaminated with HSV-1. A 1-minute exposure to 0.01% hypochlorous acid completely eradicated HSV-1 from the lens cases. This result surprised us and prompted a second trial with HSV-1 which produced the same results. The reason for the lack of efficacy of 0.01% hypochlorous acid against HSV-1 on the lenses is unknown. Perhaps there was some interaction between the enveloped virions and the lens materials (RGP and or silicone hydrogel) or their interface that protected the virus from disinfection. It does not appear that the lens materials have an inhibitory effect on the 0.01% hypochlorous acid since a 1-minute exposure was effective against multiple types of organisms in this study. There is the possibility that a longer exposure time to the 0.01% hypochlorous acid could provide more effective disinfection against HSV-1. It was beyond the scope of this study to determine the mechanisms by which the 0.01% hypochlorous acid was ineffective against HSV-1 in contaminated hybrid lenses and whether increased exposure time would increase effectiveness. This can be the focus of a future study

There was no ambiguity within the results for the disinfection of the hard plastic contact lens cases. The 0.01% hypochlorous acid completely eliminated all test organisms from the contact lens cases after only 1 minute of exposure. These results demonstrate that 0.01% hypochlorous acid is an effective disinfectant against all of these test organisms.

There are several limitations of this study. In this proof of concept study, the numbers of contact lenses and cases available to us were limited. Since we wished to test as many relevant organisms as possible, we had to sacrifice replicates for each organism. Therefore, we could only test the hypochlorous acid treatments on 2 replicate lenses and cases per organism. Unfortunately, with only 2 replicate lenses and cases per organism, a statistical analysis was not feasible. However, since the aim of the study was to determine total eradication of the organisms, this result is more qualitative. We did demonstrate total eradication of all organisms on the cases and 7/9 organisms on the lenses. Another limitation of the study was the lack of neutralization of the hypochlorous acid after the 1-minute treatment period. We are unaware of any agent that will neutralize the hypochlorous acid on contact. Instead, we used dilution and immediate plating of the solutions onto the appropriate growth medium in order to minimize the prolonged effect of the hypochlorous acid on the organisms.

The results of this study demonstrated that 0.01% hypochlorous acid (HyClear™) was effective in disinfecting hybrid contact lenses and hard plastic lens cases contaminated with bacteria, a yeast, and adenovirus. The 0.01% hypochlorous acid was effective in eliminating HSV-1 from cases but not the lenses.

Table 1: Bacterial, Fungal, (CFU/Lens) and Viral Counts (PFU/Lens) after Treatment of Contact Lenses (Log10 Mean ± Standard Deviation).

Organism Vehicle Count HA Count
Staphylococcus aureus 3.45 ± 0.01 1.19 ± 1.68***
Coagulase-negative Staphylococcus 2.75 ± 0.10 0.00 ± 0.00
Streptococcus pneumoniae 2.81 ± 0.11 0.00 ± 0.00
Pseudomonas aeruginosa 2.56 ± 0.00 0.00 ± 0.00
Serratia marcescens 3.39* 0.00 ± 0.00
Achromobacter xylosoxidans 3.07 ± 0.05 0.00 ± 0.00
Candida albicans 2.87 ± 0.11 0.00 ± 0.00
Adenovirus Type 19/64 3.78 ± 0.69 0.00 ± 0.00
HSV-1 (Trial 1) 3.64 ± 0.07 3.03 ± 0.03
HSV-1 (Trial 2) 4.35** 3.87 ± 0.05
*Only 1 Lens Tested Due to Loss of Duplicate Sample
**Only 1 Lens Tested Due to Unavailability of Additional Lenses
**Only 1 of 2 Lens Tested had Bacteria Present

 

Table 2: Bacterial, Fungal, (CFU/Case) and Viral Counts (PFU/Case) after Treatment of Contact Lens Cases (Log10 Mean ± Standard Deviation)

Organism Vehicle Count HA Count
Staphylococcus aureus 4.09 ± 0.12 0.00 ± 0.00
Coagulase-negative Staphylococcus 3.86 ± 0.17 0.00 ± 0.00
Streptococcus pneumoniae 2.68 ± 0.24 0.00 ± 0.00
Pseudomonas aeruginosa 3.39 ± 0.13 0.00 ± 0.00
Serratia marcescens 3.19 ± 0.09 0.00 ± 0.00
Achromobacter xylosoxidans 3.06 ± 0.28 0.00 ± 0.00
Candida albicans 2.95 ± 0.04 0.00 ± 0.00
Adenovirus Type 19/64 3.48 ± 0.67 0.00 ± 0.00
HSV-1 (Trial 1) 3.37 ± 0.06 0.00 ± 0.00
HSV-1 (Trial 2) 4.34 ± 0.01 0.00 ± 0.00

 

 

 

 

 

 

 

 

CONCLUSION

In conclusion, 0.01% hypochlorous acid has the potential to be used as a rapid disinfecting agent for reusable contact lens trial sets and their cases. Longer 0.01% hypochlorous exposure times should be evaluated for HSV-1 on lenses as well as disinfection testing on actual fitting lenses.

Received : 18 Sep 2020
Accepted : 29 Sep 2020
Published : 30 Sep 2020
Journals
Annals of Otolaryngology and Rhinology
ISSN : 2379-948X
Launched : 2014
JSM Schizophrenia
Launched : 2016
Journal of Nausea
Launched : 2020
JSM Internal Medicine
Launched : 2016
JSM Hepatitis
Launched : 2016
JSM Oro Facial Surgeries
ISSN : 2578-3211
Launched : 2016
Journal of Human Nutrition and Food Science
ISSN : 2333-6706
Launched : 2013
JSM Regenerative Medicine and Bioengineering
ISSN : 2379-0490
Launched : 2013
JSM Spine
ISSN : 2578-3181
Launched : 2016
Archives of Palliative Care
ISSN : 2573-1165
Launched : 2016
JSM Nutritional Disorders
ISSN : 2578-3203
Launched : 2017
Annals of Neurodegenerative Disorders
ISSN : 2476-2032
Launched : 2016
Journal of Fever
ISSN : 2641-7782
Launched : 2017
JSM Bone Marrow Research
ISSN : 2578-3351
Launched : 2016
JSM Mathematics and Statistics
ISSN : 2578-3173
Launched : 2014
Journal of Autoimmunity and Research
ISSN : 2573-1173
Launched : 2014
JSM Arthritis
ISSN : 2475-9155
Launched : 2016
JSM Head and Neck Cancer-Cases and Reviews
ISSN : 2573-1610
Launched : 2016
JSM General Surgery Cases and Images
ISSN : 2573-1564
Launched : 2016
JSM Anatomy and Physiology
ISSN : 2573-1262
Launched : 2016
JSM Dental Surgery
ISSN : 2573-1548
Launched : 2016
Annals of Emergency Surgery
ISSN : 2573-1017
Launched : 2016
Annals of Mens Health and Wellness
ISSN : 2641-7707
Launched : 2017
Journal of Preventive Medicine and Health Care
ISSN : 2576-0084
Launched : 2018
Journal of Chronic Diseases and Management
ISSN : 2573-1300
Launched : 2016
Annals of Vaccines and Immunization
ISSN : 2378-9379
Launched : 2014
JSM Heart Surgery Cases and Images
ISSN : 2578-3157
Launched : 2016
Annals of Reproductive Medicine and Treatment
ISSN : 2573-1092
Launched : 2016
JSM Brain Science
ISSN : 2573-1289
Launched : 2016
JSM Biomarkers
ISSN : 2578-3815
Launched : 2014
JSM Biology
ISSN : 2475-9392
Launched : 2016
Archives of Stem Cell and Research
ISSN : 2578-3580
Launched : 2014
Annals of Clinical and Medical Microbiology
ISSN : 2578-3629
Launched : 2014
JSM Pediatric Surgery
ISSN : 2578-3149
Launched : 2017
Journal of Memory Disorder and Rehabilitation
ISSN : 2578-319X
Launched : 2016
JSM Tropical Medicine and Research
ISSN : 2578-3165
Launched : 2016
JSM Head and Face Medicine
ISSN : 2578-3793
Launched : 2016
JSM Cardiothoracic Surgery
ISSN : 2573-1297
Launched : 2016
JSM Bone and Joint Diseases
ISSN : 2578-3351
Launched : 2017
JSM Bioavailability and Bioequivalence
ISSN : 2641-7812
Launched : 2017
JSM Atherosclerosis
ISSN : 2573-1270
Launched : 2016
Journal of Genitourinary Disorders
ISSN : 2641-7790
Launched : 2017
Journal of Fractures and Sprains
ISSN : 2578-3831
Launched : 2016
Journal of Autism and Epilepsy
ISSN : 2641-7774
Launched : 2016
Annals of Marine Biology and Research
ISSN : 2573-105X
Launched : 2014
JSM Health Education & Primary Health Care
ISSN : 2578-3777
Launched : 2016
JSM Communication Disorders
ISSN : 2578-3807
Launched : 2016
Annals of Musculoskeletal Disorders
ISSN : 2578-3599
Launched : 2016
Annals of Virology and Research
ISSN : 2573-1122
Launched : 2014
JSM Renal Medicine
ISSN : 2573-1637
Launched : 2016
Journal of Muscle Health
ISSN : 2578-3823
Launched : 2016
JSM Genetics and Genomics
ISSN : 2334-1823
Launched : 2013
JSM Anxiety and Depression
ISSN : 2475-9139
Launched : 2016
Clinical Journal of Heart Diseases
ISSN : 2641-7766
Launched : 2016
Annals of Medicinal Chemistry and Research
ISSN : 2378-9336
Launched : 2014
JSM Pain and Management
ISSN : 2578-3378
Launched : 2016
JSM Women's Health
ISSN : 2578-3696
Launched : 2016
Clinical Research in HIV or AIDS
ISSN : 2374-0094
Launched : 2013
Journal of Endocrinology, Diabetes and Obesity
ISSN : 2333-6692
Launched : 2013
Journal of Substance Abuse and Alcoholism
ISSN : 2373-9363
Launched : 2013
JSM Neurosurgery and Spine
ISSN : 2373-9479
Launched : 2013
Journal of Liver and Clinical Research
ISSN : 2379-0830
Launched : 2014
Journal of Drug Design and Research
ISSN : 2379-089X
Launched : 2014
JSM Clinical Oncology and Research
ISSN : 2373-938X
Launched : 2013
JSM Bioinformatics, Genomics and Proteomics
ISSN : 2576-1102
Launched : 2014
JSM Chemistry
ISSN : 2334-1831
Launched : 2013
Journal of Trauma and Care
ISSN : 2573-1246
Launched : 2014
JSM Surgical Oncology and Research
ISSN : 2578-3688
Launched : 2016
Annals of Food Processing and Preservation
ISSN : 2573-1033
Launched : 2016
Journal of Radiology and Radiation Therapy
ISSN : 2333-7095
Launched : 2013
JSM Physical Medicine and Rehabilitation
ISSN : 2578-3572
Launched : 2016
Annals of Clinical Pathology
ISSN : 2373-9282
Launched : 2013
Annals of Cardiovascular Diseases
ISSN : 2641-7731
Launched : 2016
Journal of Behavior
ISSN : 2576-0076
Launched : 2016
Annals of Clinical and Experimental Metabolism
ISSN : 2572-2492
Launched : 2016
Clinical Research in Infectious Diseases
ISSN : 2379-0636
Launched : 2013
JSM Microbiology
ISSN : 2333-6455
Launched : 2013
Journal of Urology and Research
ISSN : 2379-951X
Launched : 2014
Journal of Family Medicine and Community Health
ISSN : 2379-0547
Launched : 2013
Annals of Pregnancy and Care
ISSN : 2578-336X
Launched : 2017
JSM Cell and Developmental Biology
ISSN : 2379-061X
Launched : 2013
Annals of Aquaculture and Research
ISSN : 2379-0881
Launched : 2014
Clinical Research in Pulmonology
ISSN : 2333-6625
Launched : 2013
Journal of Immunology and Clinical Research
ISSN : 2333-6714
Launched : 2013
Annals of Forensic Research and Analysis
ISSN : 2378-9476
Launched : 2014
JSM Biochemistry and Molecular Biology
ISSN : 2333-7109
Launched : 2013
Annals of Breast Cancer Research
ISSN : 2641-7685
Launched : 2016
Annals of Gerontology and Geriatric Research
ISSN : 2378-9409
Launched : 2014
Journal of Sleep Medicine and Disorders
ISSN : 2379-0822
Launched : 2014
JSM Burns and Trauma
ISSN : 2475-9406
Launched : 2016
Chemical Engineering and Process Techniques
ISSN : 2333-6633
Launched : 2013
Annals of Clinical Cytology and Pathology
ISSN : 2475-9430
Launched : 2014
JSM Allergy and Asthma
ISSN : 2573-1254
Launched : 2016
Journal of Neurological Disorders and Stroke
ISSN : 2334-2307
Launched : 2013
Annals of Sports Medicine and Research
ISSN : 2379-0571
Launched : 2014
JSM Sexual Medicine
ISSN : 2578-3718
Launched : 2016
Annals of Vascular Medicine and Research
ISSN : 2378-9344
Launched : 2014
JSM Biotechnology and Biomedical Engineering
ISSN : 2333-7117
Launched : 2013
Journal of Hematology and Transfusion
ISSN : 2333-6684
Launched : 2013
JSM Environmental Science and Ecology
ISSN : 2333-7141
Launched : 2013
Journal of Cardiology and Clinical Research
ISSN : 2333-6676
Launched : 2013
JSM Nanotechnology and Nanomedicine
ISSN : 2334-1815
Launched : 2013
Journal of Ear, Nose and Throat Disorders
ISSN : 2475-9473
Launched : 2016
Journal of Pharmacology and Clinical Toxicology
ISSN : 2333-7079
Launched : 2013
Annals of Psychiatry and Mental Health
ISSN : 2374-0124
Launched : 2013
Medical Journal of Obstetrics and Gynecology
ISSN : 2333-6439
Launched : 2013
Annals of Pediatrics and Child Health
ISSN : 2373-9312
Launched : 2013
JSM Clinical Pharmaceutics
ISSN : 2379-9498
Launched : 2014
JSM Foot and Ankle
ISSN : 2475-9112
Launched : 2016
JSM Alzheimer's Disease and Related Dementia
ISSN : 2378-9565
Launched : 2014
Journal of Addiction Medicine and Therapy
ISSN : 2333-665X
Launched : 2013
Journal of Veterinary Medicine and Research
ISSN : 2378-931X
Launched : 2013
Annals of Public Health and Research
ISSN : 2378-9328
Launched : 2014
Annals of Orthopedics and Rheumatology
ISSN : 2373-9290
Launched : 2013
Journal of Clinical Nephrology and Research
ISSN : 2379-0652
Launched : 2014
Annals of Community Medicine and Practice
ISSN : 2475-9465
Launched : 2014
Annals of Biometrics and Biostatistics
ISSN : 2374-0116
Launched : 2013
JSM Clinical Case Reports
ISSN : 2373-9819
Launched : 2013
Journal of Cancer Biology and Research
ISSN : 2373-9436
Launched : 2013
Journal of Surgery and Transplantation Science
ISSN : 2379-0911
Launched : 2013
Journal of Dermatology and Clinical Research
ISSN : 2373-9371
Launched : 2013
JSM Gastroenterology and Hepatology
ISSN : 2373-9487
Launched : 2013
Annals of Nursing and Practice
ISSN : 2379-9501
Launched : 2014
JSM Dentistry
ISSN : 2333-7133
Launched : 2013
Author Information X